Myriad Genetics
MYGN
#6699
Rank
NZ$1.14 B
Marketcap
NZ$12.27
Share price
-3.27%
Change (1 day)
-55.87%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.25 Billion

According to Myriad Genetics's latest financial reports the company has NZ$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.18 B-18.51%
2023-12-31NZ$0.22 B23.11%
2022-12-31NZ$0.18 B-63.51%
2021-12-31NZ$0.49 B
2020-06-30NZ$0.33 B65.8%
2019-06-30NZ$0.20 B-23.65%
2018-06-30NZ$0.26 B29.56%
2017-06-30NZ$0.20 B-7.61%
2016-06-30NZ$0.22 B4.43%
2015-06-30NZ$0.21 B0.3%
2014-06-30NZ$0.21 B-55.79%
2013-06-30NZ$0.48 B13.4%
2012-06-30NZ$0.42 B1.46%
2011-06-30NZ$0.41 B-28.25%
2010-06-30NZ$0.58 B17.95%
2009-06-30NZ$0.49 B14.38%
2008-06-30NZ$0.43 B55.14%
2007-06-30NZ$0.27 B-25.93%
2006-06-30NZ$0.37 B125.93%
2005-06-30NZ$0.16 B-7.73%
2004-06-30NZ$0.18 B44.3%
2003-06-30NZ$0.12 B-16.87%
2002-06-30NZ$0.15 B-51.95%
2001-06-30NZ$0.31 B82.64%
2000-06-30NZ$0.17 B816.25%
1999-06-30NZ$18.69 M-33.4%
1998-06-30NZ$28.07 M21.43%
1997-06-30NZ$23.12 M19.92%
1996-06-30NZ$19.28 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
NZ$2.45 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ$1.73 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$11.48 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.55 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.38 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA